Revenue: The sum of all revenue fields included for a company's operating activities.
Anika Therapeutics Inc. (ANIK) had Revenue of $112.82M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$112.82M |
$-10.88M |
|
$49.01M |
|
$63.81M |
|
$123.87M |
|
$-11.05M |
|
$1.74M |
|
$-9.31M |
|
$-9.31M |
|
$-9.98M |
|
$-9.98M |
|
$-10.88M |
|
$-9.98M |
|
$-11.05M |
|
$-5.32M |
|
14.34M |
|
14.34M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$103.36M |
|
$40.32M |
|
$86.91M |
|
$190.27M |
|
$21.91M |
|
-- |
|
$24.90M |
|
$46.80M |
|
$143.47M |
|
$133.76M |
|
$143.47M |
|
-- |
|
| Cash Flow Statement Financials | |
$11.19M |
|
$-0.40M |
|
$-10.55M |
|
$57.16M |
|
$57.48M |
|
$0.32M |
|
$10.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|